Oncology

Latest News

Highlights From ASCO 2024
ICYMI: Highlights From ASCO 2024

December 21st 2024

Top coverage from the 2024 American Society of Clinical Oncology (ASCO) annual meeting included research topics in non-small cell lung cancer (NSCLC), multiple myeloma, metastatic colorectal cancer (mCRC), and more.

chemotherapy | Image credit: Penn Medicine
The High Cost of Shortages of Low-Cost Chemotherapy

December 19th 2024

Leukemia diagnosis | Image credit: Vitalii Vodolazskyi - stock.adobe.com
Real-World Treatment Sequences and Cost Analysis of cBTKis in CLL

December 17th 2024

FDA approved stamp in black with a red ribbon across it | Image credit: BHM - stock.adobe.com
Cosibelimab Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

December 16th 2024

Highlights From COA 2024
ICYMI: Highlights From COA 2024

December 14th 2024

Join this panel as they discuss treatment for metastatic NSCLC patients without driver mutations.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Maura Abbott, PhD, AOCNP, CPNP, RN, Columbia University School of Nursing
September 29th 2020

Dr Maura Abbott Explains How Vaccine Form Determines Patient Contraindications

Form will determine in which patient populations, and why, a vaccine is not indicated for administration, said Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions
September 28th 2020

Addressing Cancer Disparities Requires Asking Questions and Putting Aside Assumptions

Laura Joszt, MA
Speakers at Patient-Centered Oncology Care® highlighted injustices in the US health care system, the risk of financial toxicity, and how providers can do a better job to ensure their patients achieve health equity, during a panel discussion.
Dr Kashyap Patel Discusses COVID-19 Implications for PCOC® 2020
September 23rd 2020

Dr Kashyap Patel Discusses COVID-19 Implications for PCOC® 2020

The uncertainties precipitated by the coronavirus disease 2019 (COVID-19) pandemic around cancer care delivery are a challenging topic to be further addressed at this year’s Patient-Centered Oncology Care® 2020 virtual meeting.
How Oncology Practices Are Identifying, Addressing Health Needs Amid Pandemic
September 23rd 2020

How Oncology Practices Are Identifying, Addressing Health Needs Amid Pandemic

Through risk stratification and identifying social determinants of health, oncology practices are monitoring the direct and indirect effects of the pandemic, noted Jenifer Leaf Jaeger, MD, MPH, senior medical director of HealthEC.
Dr Joseph Alvarnas on Opportunities Presented by Virtual Format of PCOC® 2020
September 22nd 2020

Dr Joseph Alvarnas on Opportunities Presented by Virtual Format of PCOC® 2020

Through this year's virtual format for Patient-Centered Oncology Care® 2020, participants will be able to attend sessions, ask questions, and gain insight in an immediate, efficient way.
More Coffee, Longer Survival? Study Highlights Benefit in Metastatic Colon Cancer
September 19th 2020

More Coffee, Longer Survival? Study Highlights Benefit in Metastatic Colon Cancer

Allison Inserro
Patients with advanced colon cancer who drank 4 or more cups of coffee a day had 36% improved survival odds.
AACR Report Highlights Disparities in Cancer and the Need for Health Equity
September 18th 2020

AACR Report Highlights Disparities in Cancer and the Need for Health Equity

Laura Joszt, MA
Although innovations in cancer treatment have driven down overall cancer death rates and increased the number of survivors living with cancer, that progress has not benefitted everyone with cancer equally.
PCOC
September 9th 2020

Equity in Care Delivery Still at Top of PCOC 2020 Agenda, Amid “Undue Burden”

Mary Caffrey
Drs Joseph Alvarnas and Kashyap Patel, co-chairs of Patient-Centered Oncology Care® 2020, discuss what attendees can look forward to at the September 25 meeting.
IQVIA
September 7th 2020

Combatting COVID-19 With Real-World Evidence

Jennifer B. Christian, PharmD, MPH, PhD Matthew W. Reynolds, PhD
A vaccine isn’t the panacea many assume it will be. Even when it becomes available, the virus won’t go away. Real world evidence will be needed to guide decision making.
Picture of liver
September 5th 2020

Uptake of Palliative Care in Liver Cancer Needs Improvement, Report Says

Allison Inserro
Hepatocellular carcinoma is rising, and so is the need for increased awareness and use of palliative care, say the authors of a recent review.
Tafasitamab Plus Lenalidomide Added to NCCN Guidelines
August 28th 2020

Tafasitamab Plus Lenalidomide Added to NCCN Guidelines

AJMC Staff
NCCN added tafasitamab plus lenalidomide to their oncology practice guidelines for patients with relapsed or refractory DLBCL not otherwise specified.
Kashyap Patel, MD
August 25th 2020

When the Topic Is Dying: A Conversation With Kashyap Patel, MD

Mary Caffrey
Kashyap Patel, MD, CEO of Carolina Blood and Cancer Care, associate editor of Evidence-Based Oncology, and vice president of the Community Oncology Alliance, discusses his new book.
Psychosocial Support for Patients With Cancer Waning as COVID-19 Pandemic Continues
August 24th 2020

Psychosocial Support for Patients With Cancer Waning as COVID-19 Pandemic Continues

Jaime Rosenberg
A recent survey showed the disruption in cancer care as a result of the pandemic is worrying professionals who provide psychosocial support to patients.
Mark Trushiem, MSc
August 16th 2020

Sidebar: CMS Seeks to Fix Medicaid Best-Price Barriers in Value-Based Contracting for High-Cost Therapies in Medicaid

Mary Caffrey
Proposed CMS rules would make it easier for state Medicaid programs to smooth the way for value-based contracts for high-cost gene therapies.
Amid Effort to Shrink Cancer Disparities, Authors Say COVID-19 Will Widen Them
August 13th 2020

Amid Effort to Shrink Cancer Disparities, Authors Say COVID-19 Will Widen Them

Mary Caffrey
As the American Society of Clinical Oncology calls for more aggressive efforts to bring equity to cancer care, authors in JAMA Oncology say COVID-19 is creating wider gaps.
Tafasitamab Combination Approved for Adults With R/R DLBCL
August 2nd 2020

Tafasitamab Combination Approved for Adults With R/R DLBCL

Mary Caffrey
A new treatment option is approved for patients with a common form of non-Hodgkin lymphoma who cannot have an autologous stem cell transplant.
Site Logo
July 21st 2020

American Oncology Network, LLC Announces New Advisory Board Chair and Executive Committee

The American Oncology Network, LLC, has added 5 medical oncologists to its Executive Committee.
Site Logo
July 20th 2020

Access to Care: Burris Says United With Our Patients, We Accelerate Progress Together

Maggie L. Shaw
“We’ve had advancements, but we need to go faster,” said ASCO President Howard A. "Skip" Burris III, MD, as he stressed the importance of advancing therapies for better patient outcomes by addressing obstacles to patients’ care. “Access to care, access to clinical trials, and access to information are really key.”
Site Logo
July 14th 2020

Florida Cancer Specialists Names New CEO

Nathan H. Walcker will succeed Brad Prechtl on August 1, 2020.
Don't Delay Cancer Care During COVID-19 Crisis
July 1st 2020

Don't Delay Cancer Care During COVID-19 Crisis

Amy McNally, MD
Federal and state officials have implemented policies and safeguards to slow transmission of the virus. Most troubling were state moratoriums on “elective” surgical procedures.
Site Logo
June 19th 2020

From the Editor-in-Chief: Bigger Questions of Systems, Viruses, and the Lives of Real People

Joseph Alvarnas, MD
As I recall the early days of the HIV/AIDS pandemic, what stands out most is its profound human cost and the courage of those who helped our society transcend it. We are in the midst of a time in which the human toll of COVID-19 and the enormity of the path ahead are clear.
Site Logo
June 17th 2020

Conference Coverage: Community Oncology Alliance

Maggie L. Shaw Mary Caffrey
Coverage from the Community Oncology Alliance Virtual Meeting, held April 23-24, 2020.
Site Logo
June 17th 2020

How to Optimize Cancer Therapy When Coronavirus Hits the Fan

Afsaneh Barzi, MD, PhD Sarmad Sadeghi, MD, PhD
The American Society of Clinical Oncology recommends that cancer survivors who have completed their treatment and are under surveillance with no known evidence of disease are to be kept out of care facilities to avoid developing COVID-19.
FDA Grants Accelerated Approval to Lurbinectedin in Metastatic Small Cell Lung Cancer
June 16th 2020

FDA Grants Accelerated Approval to Lurbinectedin in Metastatic Small Cell Lung Cancer

AJMC Staff
Investigators reported in Lancet Oncology that second-line treatments are needed in small cell lung cancer, as few options exist for these patients once first-line therapy fails.
Site Logo
June 11th 2020

Claims Identification of Patients With Severe Cancer-Related Symptoms

Richard W. DeClue, PhD, MPH Dana Drzayich Antol, MS Adrianne W. Casebeer, PhD, MS, MPP Todd Michael, PharmD, RPh Marina Sehman, PharmD Andrew Renda, MD, MPH Sarika Ogale, PhD Stephen Stemkowski, PhD, MHA Bryan Loy, MD
The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.
Aaron Lyss on What the Next Oncology Payment Model Should Include
June 11th 2020

Aaron Lyss on What the Next Oncology Payment Model Should Include

Benchmarking, accountability, bilateralism, and scalability are the 4 parameters critical to successful alternative payment models in oncology, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Aaron Lyss Outlines Lessons Learned From Data Analytics
June 6th 2020

Aaron Lyss Outlines Lessons Learned From Data Analytics

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Aaron Lyss Discusses Practice Transformation Under the OCM
May 30th 2020

Aaron Lyss Discusses Practice Transformation Under the OCM

The Oncology Care Model (OCM) has helped practices develop their capacity to use data for continuous quality improvement, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.
Lili Brillstein on Mandatory, Voluntary Payment Models
May 29th 2020

Lili Brillstein on Mandatory, Voluntary Payment Models

There will never be all mandatory payment models or all value-based models, but we can craft a value-based model around just about anything as long as everybody agrees on what the criteria is, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
Lili Brillstein Outlines Challenges of Incorporating Value-Based Care in Oncology
May 18th 2020

Lili Brillstein Outlines Challenges of Incorporating Value-Based Care in Oncology

New technologies and quick drug approvals contribute to the challenges of incorporating value-based care in oncology, said Lili Brillstein, CEO of Brillstein Collaborative Consulting, and former Director for Episodes of Care at Horizon Blue Cross Blue Shield of New Jersey.
<1
...
131415161718192021
...
181>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo